Our Services
Medical Information
Helpful Resources
Published on: 12/23/2025
After diagnosis, your team confirms the cancer type and stage with biopsy review, imaging, and a pelvic exam, then a multidisciplinary group tailors a plan to your health goals and fertility preferences. Depending on stage, care may involve fertility-sparing surgery or hysterectomy, chemoradiation with brachytherapy, or systemic and palliative treatments, along with side effect management and regular follow-up. There are several factors to consider that can affect your next steps, so see the complete step-by-step details below.
Learning you’ve been diagnosed with cervical cancer can be overwhelming. This guide walks you through the typical next steps—diagnostic tests, staging, treatment options, and follow-up—using straightforward language and up-to-date clinical guidelines.
Before finalizing a treatment plan, your medical team will gather more information:
Pathology review
• A biopsy from your cervical tissue is examined under a microscope to confirm cancer type (usually squamous cell carcinoma or adenocarcinoma).
• Sometimes a second opinion by a specialized pathologist is recommended.
Imaging studies
• Magnetic resonance imaging (MRI) of the pelvis to assess tumor size and local spread.
• Computed tomography (CT) scan of chest/abdomen/pelvis or positron emission tomography (PET-CT) to check for spread beyond the pelvis.
Blood tests
• Complete blood count, kidney/liver function.
• HIV test in some settings (HIV can affect treatment choices).
Physical exam
• A detailed pelvic exam (under anesthesia if needed) to measure tumor dimensions and check nearby organs.
Accurate staging determines the extent of disease and guides treatment. Clinicians use the 2018 FIGO staging system (Pecorelli S, 2019):
Stage I: Cancer confined to the cervix.
• IA1–IA2: Microscopic invasion only.
• IB1–IB3: Visible tumors up to >4 cm.
Stage II: Spread beyond cervix into upper two-thirds of vagina or parametrial tissues, but not to pelvic wall.
Stage III: Involvement of lower vagina, pelvic wall, or causing hydronephrosis.
Stage IV: Spread to bladder/rectum mucosa (IVA) or distant organs (IVB).
Your team will assign a stage based on combined pathology and imaging findings.
Once staging is complete, your care is coordinated by a multidisciplinary team, often including:
This team tailors treatment to your stage, age, general health, and preferences.
Goal: Cure with surgery alone or combined with radiation/chemotherapy if risk factors are present.
Radical hysterectomy
• Removal of uterus, cervix, upper vagina, and parametrial tissue.
• Pelvic lymph node dissection to check for microscopic spread.
Trachelectomy (select patients wishing to preserve fertility)
• Removal of cervix and upper vagina, leaving the uterus intact.
• Sentinel lymph node biopsy or lymphadenectomy.
Adjuvant therapy (after surgery)
• Radiation ± concurrent chemotherapy (usually cisplatin) if high-risk features are found, such as positive lymph nodes, tumor >4 cm, or microscopic parametrial invasion.
Goal: Control local disease and improve survival with combined chemoradiation.
External beam radiation therapy (EBRT)
• Targets the pelvis to treat the primary tumor and regional lymph nodes.
Concurrent chemotherapy
• Weekly cisplatin is standard (Colombo et al., 2017).
• Enhances radiation effectiveness.
Brachytherapy
• Internal radiation placed directly near the cervix.
• Essential for high cure rates in locally advanced disease.
Goal: Palliation, symptom control, and life prolongation.
Systemic chemotherapy
• Platinum-based regimens (e.g., cisplatin or carboplatin plus paclitaxel).
• Bevacizumab (anti-angiogenic agent) may be added.
Palliative radiation
• To relieve pain, bleeding, or obstruction.
Supportive care
• Pain management, nutritional support, counseling, and hospice referrals when appropriate.
Treatment can cause side effects; managing them improves quality of life:
Radiation-related
• Fatigue, skin irritation, diarrhea, urinary symptoms, vaginal dryness or stenosis.
Chemotherapy-related
• Nausea, low blood counts, neuropathy, hair loss.
Surgical
• Pain, risk of infection, early menopause if ovaries removed.
Support strategies:
Regular follow-up is critical for detecting recurrence early:
Report any new symptoms—like unusual bleeding, pelvic pain, weight loss, or bowel/bladder changes—promptly to your doctor.
Cervical cancer care extends beyond medical treatment:
If standard treatments are not suitable or you’re interested in cutting-edge options, discuss clinical trials with your team. Trials may offer novel agents like immunotherapies (e.g., pembrolizumab) for advanced disease.
Certain symptoms may signal complications or serious issues—speak to your doctor right away if you experience:
You might also consider doing a free, online symptom check for extra guidance on when to seek care; try this quick symptom check for help.
Every person’s situation is unique. If you’ve been diagnosed with cervical cancer, speak to a doctor about:
Your healthcare team is your partner in navigating diagnosis, treatment, and survivorship. Early communication about any new or worsening symptoms ensures timely care.
Remember: This information is educational and not a substitute for professional medical advice. Always consult your physician or oncology team about any concerns—especially those that could be life-threatening or seriously affect your health.
(References)
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.